Longboard Pharmaceuticals Ownership | Who Owns Longboard Pharmaceuticals?
Longboard Pharmaceuticals Ownership Summary
Longboard Pharmaceuticals is owned by 102.17% institutional investors, 1.20% insiders. Fmr is the largest institutional shareholder, holding 11.36% of LBPH shares. Fidelity Select Biotechnology is the top mutual fund, with 4.38% of its assets in Longboard Pharmaceuticals shares.
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.42M | 11.36% | $119.34M |
| Farallon capital management | 2.94M | 7.56% | $79.48M |
| Cormorant asset management, lp | 2.79M | 7.18% | $75.43M |
| Price t rowe associates inc /md/ | 2.51M | 6.45% | $67.81M |
| Blackrock | 2.37M | 6.09% | $64.02M |
| Vanguard group | 1.93M | 4.95% | $52.04M |
| Wellington management group llp | 1.78M | 4.58% | $48.09M |
| Viking global investors lp | 1.66M | 4.27% | $44.84M |
| Polar capital | 1.35M | 3.48% | $36.61M |
| Integral health asset management | 1.10M | 2.83% | $29.73M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cormorant asset management, lp | 2.79M | 4.36% | $75.43M |
| Nan fung group | 144.57K | 4.17% | $3.91M |
| Ally bridge group (ny) | 218.98K | 3.53% | $5.92M |
| Integral health asset management | 1.10M | 2.82% | $29.73M |
| Parkman healthcare partners | 694.18K | 2.51% | $18.76M |
| Silverarc capital management | 122.85K | 0.78% | $3.32M |
| Saturn v capital management | 71.44K | 0.73% | $1.93M |
| Farallon capital management | 2.94M | 0.38% | $79.48M |
| Emerald mutual fund advisers trust | 183.58K | 0.26% | $4.96M |
| Emerald advisers | 228.52K | 0.26% | $6.18M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Viking global investors lp | 1.66M | 0.17% | 677.63K |
| Blackrock | 2.37M | 0.00% | 502.16K |
| Pictet asset management sa | 913.78K | 0.03% | 337.11K |
| Price t rowe associates inc /md/ | 2.51M | 0.01% | 290.54K |
| Emerald advisers | 228.52K | 0.26% | 228.52K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -3.29M |
| Point72 asset management | - | - | -1.03M |
| Cormorant asset management, lp | 2.79M | 4.36% | -562.68K |
| Wellington management group llp | 1.78M | 0.01% | -357.39K |
| Alyeska investment group | - | - | -212.88K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Emerald advisers | 228.52K | 0.26% | 228.52K | $6.18M |
| Candriam s.c.a. | 225.92K | 0.04% | 225.92K | $6.11M |
| Emerald mutual fund advisers trust | 183.58K | 0.26% | 183.58K | $4.96M |
| Silverarc capital management | 122.85K | 0.78% | 122.85K | $3.32M |
| Saturn v capital management | 71.44K | 0.73% | 71.44K | $1.93M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -2.00 |
| Lifesteps financial | -200.00 |
| Ikarian capital | -236.00 |
| Metropolitan life insurance co/ny | -1.36K |
| Point72 (difc) | -1.57K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 123 | 21.78% | 39,801,435 | 2.57% | 102 | 1.03% | 87 | 29.85% | 27 | -3.57% |
| Jun 30, 2024 | 101 | -6.48% | 38,802,383 | 2.38% | 99 | 0.87% | 67 | -27.96% | 28 | 250.00% |
| Mar 31, 2024 | 108 | 107.69% | 37,901,255 | 129.32% | 107 | 2.25% | 93 | 210.00% | 8 | -20.00% |
| Dec 31, 2023 | 52 | 1.96% | 16,527,897 | 5.54% | 69 | 1.55% | 30 | 25.00% | 10 | -28.57% |
| Sep 30, 2023 | 51 | 2.00% | 15,660,436 | 7.73% | 66 | 1.66% | 24 | -41.46% | 14 | 133.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 1.71M | 4.38% | - |
| T. Rowe Price Health Sciences | 1.11M | 2.85% | -10.79K |
| Vanguard Total Stock Mkt Idx Inv | 1.09M | 2.80% | -3.71K |
| Polar Capital Biotech S Inc | 1.00M | 2.56% | - |
| T. Rowe Price New Horizons | 901.56K | 2.32% | -2.84K |
| US Small-Cap Growth II Equity Comp | 901.56K | 2.32% | 30.99K |
| Fidelity Global Innovators Cl F | 842.55K | 2.17% | -3.53K |
| iShares Russell 2000 ETF | 831.97K | 2.13% | -1.88K |
| Pictet-Biotech P USD | 532.43K | 1.36% | -2.93K |
| Fidelity Series Small Cap Opps | 499.80K | 1.28% | -21.70K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 15, 2024 | Kaye Randall | CMO | Sell | $983.94K |
| Sep 16, 2024 | Kaye Randall | CMO | Sell | $133.62K |
| Sep 16, 2024 | Kaye Randall | CMO | Sell | $39.75K |
| Sep 16, 2024 | Kaye Randall | CMO | Sell | $64.67K |
| Sep 16, 2024 | Kaye Randall | CMO | Sell | $289.28K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | 6 |
| 2024 Q2 | - | 1 |
| 2024 Q1 | 1 | 1 |
| 2023 Q2 | - | - |
LBPH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools